ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 638645 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 638645; 2) Community: the network communities that were significantly associated with the response to NSC 638645; 3) Molecule: the relationships between components within communities and NSC 638645; 4) MDR: the compounds that were significantly associated with the NSC 638645.

NSC Compound Enrichment Correlation
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.029142074732756 0.47742763
NSC 744023 (11aS)-8-(3-{4-[(E)-3-(2-hydroxyphenyl)-3-oxo-1-propenyl]-2-methoxyphenoxy}propoxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.029142074732756 0.37018218
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.029142074732756 0.37676457
NSC 750050 Null 0.029142074732756 0.27176133
NSC 753598 Null 0.029142074732756 0.31358269
NSC 755442 Null 0.029142074732756 0.25532048
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.029142074732756 0.18818082
NSC 85561 3-hydroxy-4-((1-hydroxynaphthalen-2-yl)diazenyl)-7-nitronaphthalene-1-sulfonic acid, sodium sallt 0.029142074732756 0.24166494
NSC 92207 Null 0.029142074732756 0.41951174
NSC 93819 Depakine 0.029142074732756 -0.10812762
Total:112  Current:87    [First] [Prev] [Next] [Last]